
Stallion India Fluorochemicals: IPO Proceeds Monitoring Report Shows Deviation
Stallion India Fluorochemicals Ltd has submitted its Monitoring Agency Report for the quarter ended September 30, 2026, concerning the utilization of its Initial Public Offer (IPO) proceeds. CARE Ratings Limited, the monitoring agency, reported a deviation. The company utilized ₹0.40 crore from its own funds, which was parked in an FD, towards the IPO objects. This is considered a deviation as it's contrary to the prospectus, which stipulates monitoring of IPO funds, not the company's own funds. The deviation is within the 10% range. The total IPO size was ₹160.73 crore.
Key Highlights
- Monitoring Agency Report for IPO proceeds submitted for Q2FY27.
- Deviation noted in utilization of IPO funds.
- Company used ₹0.40 crore of own funds, contrary to prospectus.
- Deviation is within the 10% range as per CARE Ratings.
- Total IPO size was ₹160.73 crore.
Price Impact
More from STALLION
Stallion India Fluorochemicals Q2 FY27 Revenue Up 31.8% YoY
Stallion India Fluorochemicals: Monitoring Agency Report for Rights Issue
Stallion India Q2 PAT sinks 79% YoY to ₹2.45 Cr as input costs, ESOP charge crush margins